A team of paediatric specialists, including an expert from the University of Adelaide, has produced new guidelines regarding assessment and management of type 2 diabetes (T2D) in Australian and New Zealand children and adolescents.
Preeclampsia is a dangerous condition that worldwide kills over 70,000 women and 500,000 babies each year. The discovery of two new biomarkers has the potential to predict key underlying causes of the disease and could lead to the early diagnosis and prevention of severe preeclampsia, and associated complications, researchers say.
Health care providers may unintentionally expose patients to endocrine- disrupting chemicals (EDCs) by prescribing certain medications and using medical supplies, according to a perspective published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
People with endocrine disorders may see their condition worsen as a result of COVID-19, according to a new review published in the Journal of the Endocrine Society.
Scientists from the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine have developed a method allowing for the long-term culture of 'pancreatic slices' to study the regeneration of the human pancreas in real time.
Perimenopause is a time when women become more vulnerable to a number of health problems. A new study based on data from the Canadian Longitudinal Study on Aging identified menopause as a risk factor for the development of metabolic syndrome or some of its components, including hypertension, central obesity, and high blood sugar. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).
Largest US database of pregnant women with type 1 diabetes provides a first-time, big picture view of mother's health, and neonatal and delivery outcomes. The analysis found a threefold increase in insulin pump use at the end of the study period, compared to the start of the study, but A1c levels remained steady across the 13-year period. Over time the study showed a trend toward pre-pregnancy obesity and unhealthy maternal weight gain.
A comparison of glucose-lowering drugs suggests that metformin-based therapy may be a preferred first-line treatment for drug-naive patients with type 2 diabetes at low cardiovascular risk. There is not enough evidence to reach a conclusion about the optimal initial treatment of drug-naive patients at increased cardiovascular risk. Findings from a systematic review and network meta-analysis are published in Annals of Internal Medicine.
The latest Johns Hopkins Medicine research achievements and clinical advances, covering topics not related to COVID-19 or the SARS-CoV-2 virus.
Women with premature ovarian insufficiency (POI) become estrogen deficient at an early age, which makes them more vulnerable to the loss of bone mineral density. A new study suggests that use of continuous combined oral contraceptives may be especially effective in reducing bone mass loss. Study results are published online today in Menopause, the journal of The North American Menopause Society (NAMS).